Centrfuge integrates symbiotic liquidity and expands $1.6 billion Janus/NYLIM

Centrifuge expands tokenized fund liquidity options with the introduction of Symbiotic's Liquid Lane

Centrifuge expands the tokenized fund liquidity options by integrating Symbiotic's Liquid Lane into its three products, allowing eligible holders to exchange fund positions for USDC. This upgrade is designed to allow users to complete redemptions more immediately, while the fund's regular redemption process can be carried out independently.

The integration covers the following products: Janus Henderson's JAAA (an AAA rated mortgage bond (CLO) strategy), Janus Henderson's JTRSY (a short-term U.S. Treasury strategy), and New York Life Investment Management's HYB (a U.S. high-yield corporate bond strategy). The announcement shows that the total asset management scale of these funds is approximately US$1.6 billion.

Core Points

Centrfuge has introduced Symbiotic's Liquid Lane into three tokenized funds, providing eligible holders with another way to obtain USDC. Liquid Lane uses an on-chain inquiry (RFC) market that allows market makers to obtain liquidity from vaults to respond to redemption needs. Investors can receive the USDC immediately, while redemptions of underlying tokenized funds can be processed separately through the issuer or through an RFQ. Centrifuge has previously provided instant redemption services through partners such as Wintermute and other liquidity arrangements, while Liquid Lane focuses on transaction capital structures. The core idea of the project is that as tokenized assets become more widely used in the chain, aggregated redemption processes across issuers and asset classes are expected to improve liquidity economics.

How Symbiotic's Liquid Lane changes the redemption process

Symbiotic's Liquid Lane is built around an on-chain inquiry (RFC) market. When redemption requests are made, market makers can obtain liquidity from Symbiotic vaults to satisfy those requests. After obtaining fund tokens through an RFQ interaction, the market maker has the option to redeem the token from the issuer or transfer/sell the token through another RFQ transaction. This design is important because it separates users 'immediate liquidity needs from the slowness of traditional redemption cycles. In Centrfuge's settings, eligible investors can receive USDC immediately, while the fund's regular redemption process proceeds at its own pace. Symbiotic does not position Liquid Lane as the only redemption route, but instead uses it as an additional liquidity path designed to increase participation and improve execution efficiency for tokenized fund holders.

Why choose Centrfuge and these specific funds

Centrifuge is an asset tokenization and treasury platform where asset management companies issue and manage tokenized funds. The three products integrated with Liquid Lane cover an important part of Centrifuge's institutional business, covering structured credit, short-term Treasury bonds and high-yield corporate bonds. Janus Henderson, through its JAAA and JTRSY products, has contributed significantly to Centrifuge's growth-an expansion that is closely tied to Centrifuge's previous progress in attracting institutional demand. As of December 2025, Token Terminal estimates Centrifuge has attracted approximately $1.3 billion in new capital inflows, primarily from Janus Henderson's two funds. Token Terminal also reported that JAAA alone has locked in a total value of approximately US$1 billion and is one of the largest tokenized funds on the market.

Liquid Lane coexistence with existing instant liquidity channels

Liquid Lane is not the first liquidity solution connected to Centrfuge tokenized funds. Felix Lutsch, head of ecology at Symbiotic, said the network is not trying to replace previous solutions, but rather emphasizes that multiple mobility paths can coexist. According to Centrfuge's own disclosure, its announcement in February 2025 of a partnership with Wintermute supports JTRSY's 24/7 instant redemption. In addition, HYB launched in June with an alternative arrangement for near-instant redemption. Lutsch said Liquid Lane's differentiation is not mainly about speed, but about the capital structure used to enforce redemption needs. According to him, Liquid Lane's RFQ market can involve multiple market makers and curators without requiring each market maker to reserve inventory for specific assets in advance. This difference is related to a broader market constraint: Lutsch points out that while tokenized asset markets can provide settlement advantages, historically low trading volumes have reduced market makers 'incentive to invest capital. He believes that as tokenized funds are increasingly used as collateral and financing assets in the on-chain market, routing and aggregating redemption demand across issuers and asset classes can improve liquidity economics. From an investor's perspective, the practical significance is that as liquidity providers face less inventory burdens and are able to expand participation across assets, users may have more execution options-thereby reducing friction when redemption demand rises.

What to focus on next

As Centrifuge expands Symbiotic's Liquid Lane to more fund products, and tokenized fund liquidity competes among multiple RFQs and instant redemption mechanisms, investors should focus on whether transaction and redemption volumes are enough to attract and maintain market makers 'participation-because Liquid Lane's argument relies on improving the economy of traffic-driven liquidity.